Published in BMC Health Serv Res on December 08, 2006
Foodborne outbreak of hepatitis A, November 2007-January 2008, Austria. Eur J Clin Microbiol Infect Dis (2008) 0.83
A Bayesian network model for analysis of detection performance in surveillance systems. AMIA Annu Symp Proc (2009) 0.75
Hepatitis E in a food handler--a rapid risk assessment to guide the public health response. Western Pac Surveill Response J (2014) 0.75
Foodborne Infectious Diseases Mediated by Inappropriate Infection Control in Food Service Businesses and Relevant Countermeasures in Korea. Osong Public Health Res Perspect (2017) 0.75
An outbreak of hepatitis A associated with green onions. N Engl J Med (2005) 3.89
A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N Engl J Med (1999) 3.09
Foodborne viruses: an emerging problem. Int J Food Microbiol (2004) 2.32
Infectious disease outbreaks related to drinking water in Canada, 1974-2001. Can J Public Health (2006) 2.31
Early identification of common-source foodborne virus outbreaks in Europe. Emerg Infect Dis (2003) 1.75
Hepatitis A transmitted by food. Clin Infect Dis (2004) 1.60
Outbreak investigations--a perspective. Emerg Infect Dis (1998) 1.58
Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med (2002) 1.55
Hepatitis A--the price of progress. N Engl J Med (2005) 1.52
Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics (2002) 1.30
Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults. Hepatology (2003) 1.13
Molecular epidemiology of foodborne hepatitis a outbreaks in the United States, 2003. J Infect Dis (2005) 1.06
Viral hepatitis in a Canadian street-involved population. Can J Public Health (2002) 1.05
The economics of vaccinating restaurant workers against hepatitis A. Vaccine (2001) 1.04
The cost of a food-borne outbreak of hepatitis A in Denver, Colo. Arch Intern Med (1996) 1.03
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review. BMC Infect Dis (2005) 0.98
Hepatitis A vaccination during an outbreak among gay men in Montréal, Canada, 1995-1997. J Epidemiol Community Health (2001) 0.92
Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old. Pediatr Infect Dis J (2005) 0.92
The changing picture of hepatitis A in the United States. Curr Opin Pediatr (2004) 0.91
Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J (2003) 0.89
Hepatitis A vaccines: the growing case for universal immunisation of children. Expert Opin Pharmacother (2005) 0.88
Foodborne transmission of hepatitis A--Massachusetts, 2001. MMWR Morb Mortal Wkly Rep (2003) 0.84
Hepatitis A infected food handler at an Edmonton, Alberta retail food facility: public health protection strategies. Can Commun Dis Rep (2001) 0.83
Cost effectiveness of vaccinating food service workers against hepatitis A infection. J Food Prot (2000) 0.81
Hepatitis A in restaurant clientele and staff--Quebec. Can Commun Dis Rep (1998) 0.81
Hepatitis A immunization strategies: universal versus targeted approaches. Clin Pediatr (Phila) (2005) 0.80
Hepatitis A vaccine: is it being used to best advantage? CMAJ (2002) 0.79
Preventing foodborne disease--what clinicians can do. N Engl J Med (2004) 0.77
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol (2007) 13.46
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ (2003) 10.80
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med (2003) 10.28
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem (2003) 8.13
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem (2003) 7.92
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med (2006) 6.34
Hypothermia therapy after traumatic brain injury in children. N Engl J Med (2008) 6.10
The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol (2013) 5.93
How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med (2007) 5.86
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85
Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev (2012) 4.36
Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer. J Clin Oncol (2014) 4.31
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials (2010) 4.28
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health (2013) 4.22
CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials (2008) 4.17
Human metapneumovirus infections in hospitalized children. Emerg Infect Dis (2003) 3.99
An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol (2009) 3.98
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 3.96
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
CONSORT 2010 changes and testing blindness in RCTs. Lancet (2010) 3.68
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 3.64
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med (2010) 3.63
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med (2012) 3.63
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) (2007) 3.51
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev (2012) 3.37
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33
The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology (2005) 3.33
The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology (2005) 3.33
Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. PLoS Med (2008) 3.22
EQUATOR: reporting guidelines for health research. Lancet (2008) 3.15
Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther (2009) 3.15
An international registry of systematic-review protocols. Lancet (2010) 3.12
Should meta-analysts search Embase in addition to Medline? J Clin Epidemiol (2003) 3.06
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol (2003) 3.02
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg (2011) 3.00
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract (2004) 2.99
The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev (2012) 2.86
Evidence summaries: the evolution of a rapid review approach. Syst Rev (2012) 2.81
The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet (2005) 2.81
Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA (2003) 2.73
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology (2003) 2.73
An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis (2007) 2.63
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis (2009) 2.59
The changing age and seasonal profile of pertussis in Canada. J Infect Dis (2002) 2.53
Randomized trials published in some Chinese journals: how many are randomized? Trials (2009) 2.52
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ (2011) 2.50
Registering systematic reviews. CMAJ (2009) 2.47
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement. J Evid Based Med (2010) 2.44
Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol (2003) 2.42
Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis (2010) 2.41
Acupuncture in poststroke rehabilitation: a systematic review and meta-analysis of randomized trials. Stroke (2010) 2.41
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
Benefits and harms associated with the practice of bed sharing: a systematic review. Arch Pediatr Adolesc Med (2007) 2.34
PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med (2012) 2.31
A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals. Eval Health Prof (2002) 2.29
Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research. BMC Med (2008) 2.25
Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med (2010) 2.24
The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep (2013) 2.22
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Pharmacoeconomics (2013) 2.21
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ (2013) 2.21
Abstracts of randomized controlled trials presented at the society for pediatric research meeting: an example of publication bias. Arch Pediatr Adolesc Med (2002) 2.15
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med (2010) 2.14
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother (2010) 2.13
The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep (2013) 2.11
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol (2010) 2.10
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem Lab Med (2003) 2.10
The problem of duplicate systematic reviews. BMJ (2013) 2.06
A practical approach to evidence-based dentistry: IX: how to appraise and use an article about economic analysis. J Am Dent Assoc (2015) 1.99
A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol (2006) 1.95